HER2 (also known as ERBB2) is a key oncogene in breast cancer and is found in 2–4% of patients with non-small-cell lung ...

CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has announced it will award US$2 million to Immunethep SA to develop a conjugated peptide-based vaccine to prevent ...

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

The scientists demonstrate that it is possible to specifically deliver the treatment to the muscle stem cells, avoiding ...

Recently, a research team led by Professor Zhi-Guo Zhang from Beijing University of Chemical Technology, in collaboration ...